Anebulo Pharmaceuticals I... (ANEB)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
1.63
-0.01 (-0.61%)
At close: Jan 15, 2025, 12:59 PM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year | FY24 | FY23 | FY22 | FY21 | FY20 |
PE Ratio | -8.44 | -5.02 | -17.82 | -5.26 | -964.21 |
PS Ratio | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 18.15 | 5.56 | 8.06 | 7.44 | -983.93 |
P/FCF Ratio | -8.55 | -6.09 | -22.33 | -32.68 | -1.12K |
P/OCF Ratio | -8.55 | -6.09 | -22.33 | -32.68 | -1.12K |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | n/a | n/a | n/a | n/a | -1.18 |
Quick Ratio | 13.46 | 21.04 | 28.39 | 82.71 | 13.53 |
Current Ratio | 13.46 | 21.04 | 28.39 | 82.71 | 13.53 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | -931.69 | -307.11 | -134.8 |
Return on Equity (ROE) | -2.15 | -1.11 | -0.45 | -1.41 | 1.02 |
Return on Assets (ROA) | -2.01 | -1.01 | -0.44 | -1.4 | -0.06 |
Return on Capital (ROIC) | -2.18 | -1.06 | -0.45 | -0.17 | -0.06 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a |